Publication:
The rational use of qinghaosu and its derivatives : What is the future of new compounds ?

Simple item page
dc.contributor.authorS. Looareesuwanen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-04T08:06:23Z
dc.date.available2018-07-04T08:06:23Z
dc.date.issued1998-12-01en_US
dc.description.abstractIn Thailand, artesunate and artemether are the mainly used antimalarials for treatment of severe or multidrug resistant falciparum malaria. However, their availability (supply) and the registration requirements are the major limitations for their large-scale use. At Bangkok Hospital for Tropical Diseases, Thailand, we have studied the new artemisinin derivatives, dihydroartemisinin and arteether, and artesunate suppositories. We found that the three preparations are well tolerated, safe, and efficacious.en_US
dc.identifier.citationMedecine Tropicale. Vol.58, No.3 SUPPL. 1 (1998), 89-92en_US
dc.identifier.issn0025682Xen_US
dc.identifier.other2-s2.0-0006901844en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/18364
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0006901844&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleThe rational use of qinghaosu and its derivatives : What is the future of new compounds ?en_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0006901844&origin=inwarden_US

Files

Collections

Scopus 1991-2000